Non‐invasive prenatal testing: Navigating the ethical, legal, and social frontiers of modern obstetric practice
Year: 2025
Type: editorial
Abstract: Non-invasive prenatal testing: Navigating the ethical, legal, and social frontiers of modern obstetric practiceThe clinical advent of non-invasive prenatal testing (NIPT) has transformed prenatal care by enabling the early detection of common chromosomal aneuploidies, including trisomy 21, trisomy 18, and trisomy 13. 1 Relying on analysis of cell-free fetal DNA in maternal plasma, NIPT offers a highly sensitive and specific alternative to traditional screening, with a reduced risk of iatrogenic miscarriage compared to invasive diagnostic procedures such as amniocentesis or chorionic villus sampling.2 While a growing body of literature has examined the ethical implications of NIPT, especially in relation to routinization 3,4 and the expanded screening panels, 5 these debates have remained largely abstract or theoretical.A significant gap persists in translating these concerns into concrete, context-sensitive policy frameworks that address legal accountability, regulatory infrastructure, and equitable implementation.This gap is particularly urgent in under-regulated jurisdictions where NIPT is rapidly adopted without parallel development of governance mechanisms.This editorial makes a novel contribution by moving beyond descriptive ethical analysis to propose an interdisciplinary, practiceoriented framework for regulating NIPT.It synthesizes legal precedent, policy analysis, and clinical ethics to offer operational tools for managing ethical risk in real-world settings, with a particular focus on countries like Ireland, where private-market delivery and regulatory fragmentation risk undermining informed and equitable access.In doing so, this piece reframes the NIPT debate from abstract ethical critique toward justice-drive, enforceable safeguards in law, clinical practice, and health policy.Despite its diagnostic sophistication, NIPT is not a definitive diagnostic test, and this distinction is critical.It remains subject to both false positives and false negatives due to a range of biological and technical limitations.Key challenges include confined placental mosaicism, low fetal fraction-especially in early gestation or patients with elevated body mass
DOI: 10.1002/ijgo.70534
Authors: Rachel O'Keeffe, Samantha Doyle
Institution: National Maternity Hospital
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4414085033